Results
1
-
10
of
109
<
1
2
3
...
10
11
>
Schaeffer T.
Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics.
,
Journal of medical toxicology : official journal of the American College of Medical Toxicology
[DOI: 10.1007/s13181-012-0270-y]
Walter C; Knothe C; L?tsch J.
Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations.
,
Clinical pharmacokinetics
[DOI: 10.1007/s40262-015-0362-3]
In Vitro Drug Release After Crushing: Evaluation of Xtampza<sup>?</sup> ER and Other ER Opioid Formulations.
,
Clinical Drug Investigation
[DOI: 10.1007/s40261-017-0561-9]
Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin? with abuse-deterrent properties.
,
BMC Pharmacology and Toxicology
[DOI: 10.1186/s40360-016-0064-y]
Opioid doses required for pain management in lung cancer patients with different cholesterol levels: negative correlation between opioid doses and cholesterol levels.
,
Lipids in Health and Disease
[DOI: 10.1186/s12944-016-0212-9]
Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?
,
Supportive Care in Cancer
[DOI: 10.1007/s00520-013-1973-6]
Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update with a focus on recent interventions.
,
BMC Health Services Research
[DOI: 10.1186/1472-6963-14-90]
Pharmacokinetics, tolerability, and safety of intranasal administration of reformulated OxyContin(?) tablets compared with original OxyContin (?) tablets in healthy adults.
,
Clinical Drug Investigation
[DOI: 10.1007/s40261-013-0085-x]
Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy.
,
European Journal of Clinical Pharmacology
[DOI: 10.1007/s00228-012-1267-9]
Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?
,
Supportive Care in Cancer
[DOI: 10.1007/s00520-011-1147-3]
<
1
2
3
...
10
11
>